Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Peter-Paul M. Willemse, Rutger W. van der Meer, Jacobus Burggraaf, Saskia G. C. van Elderen, Marieke L. de Kam, Albert de Roos, Hildo J. Lamb & Susanne Osanto. (2014) Abdominal visceral and subcutaneous fat increase, insulin resistance and hyperlipidemia in testicular cancer patients treated with cisplatin-based chemotherapy. Acta Oncologica 53:3, pages 351-360.
Read now
Read now
Sarah Kohn, Milo Fradis, Eliezer Robinson & Theodore C. Iancu. (2005) Hepatotoxicity of Combined Treatment with Cisplatin and Gentamicin in the Guinea Pig. Ultrastructural Pathology 29:2, pages 129-137.
Read now
Read now
Pasqualina M. Picciotti, Angela Torsello, Italo Cantore, Egidio Stigliano, Gaetano Paludetti & Federica I. Wolf. (2005) Expression of vascular endothelial growth factor and its receptors in the cochlea of various experimental animals. Acta Oto-Laryngologica 125:11, pages 1152-1157.
Read now
Read now
Brian Eyden. (1999) Readers' Forum. Ultrastructural Pathology 23:5, pages 355-357.
Read now
Read now
Articles from other publishers (24)
Dorit Samocha-Bonet, Buffy Wu & David K. Ryugo. (2021) Diabetes mellitus and hearing loss: A review. Ageing Research Reviews 71, pages 101423.
Crossref
Crossref
Archana Ramgopal, Shiva Sridar, Jignesh Dalal & Ramasubramanian Kalpatthi. (2021) Thrombotic Microangiopathy: Multi-Institutional Review of Pediatric Patients Who Underwent HSCT. Journal of Personalized Medicine 11:6, pages 467.
Crossref
Crossref
Vijaya Lakshmi Bodiga, Jagadeesh Bathula, Madhukar Rao Kudle, Praveen Kumar Vemuri & Sreedhar Bodiga. (2020) Andrographolide suppresses cisplatin-induced endothelial hyperpermeability through activation of PI3K/Akt and eNOS –derived nitric oxide. Bioorganic & Medicinal Chemistry 28:23, pages 115809.
Crossref
Crossref
Aurélien Bourquard, Alberto Pablo-Trinidad, Ian Butterworth, Álvaro Sánchez-Ferro, Carolina Cerrato, Karem Humala, Marta Fabra Urdiola, Candice Del Rio, Betsy Valles, Jason M. Tucker-Schwartz, Elizabeth S. Lee, Benjamin J. Vakoc, Timothy P. Padera, María J. Ledesma-Carbayo, Yi-Bin Chen, Ephraim P. Hochberg, Martha L. Gray & Carlos Castro-González. (2018) Non-invasive detection of severe neutropenia in chemotherapy patients by optical imaging of nailfold microcirculation. Scientific Reports 8:1.
Crossref
Crossref
Vijaya Lakshmi Bodiga, Madhukar Rao Kudle & Sreedhar Bodiga. (2015) Silencing of PKC-α, TRPC1 or NF-κB expression attenuates cisplatin-induced ICAM-1 expression and endothelial dysfunction. Biochemical Pharmacology 98:1, pages 78-91.
Crossref
Crossref
Ayako Watanabe, Akiko Tanabe, Risa Maruoka, Kiyoko Nakamura, Koji Hatta, Yoshihiro J. Ono, Yoshito Terai & Masahide Ohmichi. (2014) Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study. International Journal of Clinical Oncology 20:4, pages 829-838.
Crossref
Crossref
Minmin Zhu, Jiawei Chen, Hua Yin, Hui Jiang, Meilin Wen & Changhong Miao. (2014) Propofol protects human umbilical vein endothelial cells from cisplatin-induced injury. Vascular Pharmacology 61:2-3, pages 72-79.
Crossref
Crossref
Arash Bidadkosh, Fatemeh Eini, Maryam Mohseni, Amir Mahmud Rastegar, Hamid Fallahi, Majid Roshanzamir & Saleh Yazdani. (2012) Vitamin C dose-dependently ameliorates renal hemodynamic toxicity of cisplatin in adult Swiss albino rats: a histopathologic and biochemical study. Comparative Clinical Pathology 23:2, pages 269-274.
Crossref
Crossref
Sima Jilanchi, Mehdi Nematbakhsh, Mehrnoosh Bahadorani, Ardeshir Talebi, Fatemeh Eshraghi-Jazi, Azam Mansouri & Farzaneh Ashrafi. (2013) Vitamin E Is a Nephroprotectant Agent in Male but Not in Female in a Model of Cisplatin-Induced Nephrotoxicity. ISRN Nephrology 2013, pages 1-6.
Crossref
Crossref
Aspasia Soultati, Giannis Mountzios, Chrysoula Avgerinou, George Papaxoinis, Dimitrios Pectasides, Meletios-Athanassios Dimopoulos & Christos Papadimitriou. (2012) Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications. Cancer Treatment Reviews 38:5, pages 473-483.
Crossref
Crossref
Gokhan Koc, Taner Rauf Divrik, Nuri Unlu, Volkan Bulut & Ferruh Zorlu. (2011) Does cisplatin-based chemotherapy effect on blood lipid levels of patients with germ cell testicular tumor in long-term follow-up?. International Urology and Nephrology 43:4, pages 1095-1100.
Crossref
Crossref
Ou Xu, Yanxing Liu, Xiaoming Li, Yi Yang, Zaixing Zhang, Na Wang, Ying Zhang & Hong Lu. (2011) Protective effects of Salvia miltiorrhiza against cisplatin-induced ototoxicity in guinea pigs. American Journal of Otolaryngology 32:3, pages 228-234.
Crossref
Crossref
Minghua Yu, Jianqun Han, Peilin Cui, Min Dai, Hongwei Li, Jian Zhang & Ruijuan Xiu. (2008) Cisplatin up-regulates ICAM-1 expression in endothelial cell via a NF-κB dependent pathway. Cancer Science 99:2, pages 391-397.
Crossref
Crossref
E D Batts & H M Lazarus. (2007) Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?. Bone Marrow Transplantation 40:8, pages 709-719.
Crossref
Crossref
J. H. Oh, D. D. Baum, S. Pham, M. Cox, S. T. Nguyen, J. Ensor & I. Chen. (2007) Long-term complications of platinum-based chemotherapy in testicular cancer survivors. Medical Oncology 24:2, pages 175-181.
Crossref
Crossref
Natalie L.M. Cappaert, Sjaak F.L. Klis, Jeroen Wijbenga & Guido F. Smoorenburg. (2005) Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid. Hearing Research 203:1-2, pages 80-87.
Crossref
Crossref
B. L’Azou, P. Fernandez, R. Bareille, M. Beneteau, C. Bourget, J. Cambar & L. Bordenave. (2005) In vitro endothelial cell susceptibility to xenobiotics: Comparison of three cell types. Cell Biology and Toxicology 21:2, pages 127-137.
Crossref
Crossref
Francisca L.C. Wolters, Sjaak F.L. Klis, Frank P.T. Hamers, John C.M.J. de Groot & Guido F. Smoorenburg. (2004) Perilymphatic application of α-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin. Hearing Research 189:1-2, pages 31-40.
Crossref
Crossref
James P. StevensonMark RosenWeijing SunMaryann GallagherDaniel G. HallerDavid VaughnBruce GiantonioRoss ZimmerWilliam P. PetrosMichael StratfordDavid ChaplinScott L. YoungMitchell SchnallPeter J. O’Dwyer. (2003) Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow. Journal of Clinical Oncology 21:23, pages 4428-4438.
Crossref
Crossref
Ken-ichi Watanabe, Shunta Inai, Ken Jinnouchi, Shunkichi Baba & Toshiaki Yagi. (2003) Expression of caspase-activated deoxyribonuclease (CAD) and caspase 3 (CPP32) in the cochlea of cisplatin (CDDP)-treated guinea pigs. Auris Nasus Larynx 30:3, pages 219-225.
Crossref
Crossref
Francisca L.C Wolters, Sjaak F.L Klis, John C.M.J de Groot, Frank P.T Hamers, Diane M Prieskorn, Josef M Miller & Guido F Smoorenburg. (2003) Systemic co-treatment with α-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs. Hearing Research 179:1-2, pages 53-61.
Crossref
Crossref
Francisca L.C Wolters, Thijn F de Vocht, Sjaak F.L Klis, Frank P.T Hamers & Guido F Smoorenburg. (2002) Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity. Hearing Research 172:1-2, pages 110-117.
Crossref
Crossref
Janine Nuver, Andries J Smit, Aleida Postma, Dirk Th Sleijfer & Jourik A Gietema. (2002) The metabolic syndrome in long-term cancer survivors, and important target for secondary preventive measures. Cancer Treatment Reviews 28:4, pages 195-214.
Crossref
Crossref
Kathleen C.M. Campbell, Robert P. Meech, Leonard P. Rybak & Larry F. Hughes. (1999) D-Methionine protects against cisplatin damage to the stria vascularis. Hearing Research 138:1-2, pages 13-28.
Crossref
Crossref